Seres Therapeutics

www.serestherapeutics.com
200 Sidney Street
Cambridge, MA 2139

Company Info

Phone
(617) 945-9626

Year Established
2010

Ticker
MCRB

Exchange
NASDAQ

Contacts

Eric Shaff
President & CEO

Thomas J. DesRosier
CLO

David Ege
CTO

Matthew Henn
CSO

Lisa von Moltke
CMO

Marella Thorell
CFO

Terri Young
CCO

Company Description

Seres Therapeutics is a late-clinical stage biotechnology company working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.